BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33665342)

  • 21. Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysis.
    Eikelboom WS; Pan M; Ossenkoppele R; Coesmans M; Gatchel JR; Ismail Z; Lanctôt KL; Fischer CE; Mortby ME; van den Berg E; Papma JM
    Alzheimers Res Ther; 2022 Apr; 14(1):48. PubMed ID: 35379344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile.
    Donaghy PC; Ciafone J; Durcan R; Hamilton CA; Barker S; Lloyd J; Firbank M; Allan LM; O'Brien JT; Taylor JP; Thomas AJ
    Psychol Med; 2022 Apr; 52(6):1147-1155. PubMed ID: 32840196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between specific neuropsychiatric disturbances in people with Alzheimer's disease and dementia with Lewy bodies and carer distress.
    Terum TM; Testad I; Rongve A; Aarsland D; Svendsboe E; Andersen JR
    Int J Geriatr Psychiatry; 2019 Oct; 34(10):1421-1428. PubMed ID: 31050041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: A longitudinal study.
    Wright LM; Donaghy PC; Burn DJ; Taylor JP; O'Brien JT; Yarnall AJ; Matthews FE; Firbank MJ; Thomas AJ; Lawson RA
    Parkinsonism Relat Disord; 2023 Aug; 113():105762. PubMed ID: 37441886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    Defrancesco M; Marksteiner J; Kemmler G; Dal-Bianco P; Ransmayr G; Benke T; Mosbacher J; Höller Y; Schmidt R
    J Alzheimers Dis; 2020; 73(1):125-133. PubMed ID: 31744004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    Rosenberg PB; Lanctôt KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R
    J Alzheimers Dis; 2016 Aug; 54(1):373-81. PubMed ID: 27567808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    D'Onofrio G; Panza F; Sancarlo D; Paris FF; Cascavilla L; Mangiacotti A; Lauriola M; Paroni GH; Seripa D; Greco A
    J Alzheimers Dis; 2016; 51(2):427-37. PubMed ID: 26890768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    Fonseca LM; Mattar GP; Haddad GG; Burduli E; McPherson SM; Guilhoto LMFF; Yassuda MS; Busatto GF; Bottino CMC; Hoexter MQ; Chaytor NS
    J Alzheimers Dis; 2021; 81(1):137-154. PubMed ID: 33749644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia.
    Giil LM; Solvang SH; Giil MM; Hellton KH; Skogseth RE; Vik-Mo AO; Hortobágyi T; Aarsland D; Nordrehaug JE
    J Alzheimers Dis; 2019; 68(1):239-253. PubMed ID: 30775974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body Dementia.
    Borda MG; Aarsland D; Tovar-Rios DA; Giil LM; Ballard C; Gonzalez MC; Brønnick K; Alves G; Oppedal K; Soennesyn H; Vik-Mo AO
    J Am Geriatr Soc; 2020 Oct; 68(10):2257-2263. PubMed ID: 32738062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious.
    Honjo Y; Ide K; Takechi H
    Psychogeriatrics; 2022 May; 22(3):317-323. PubMed ID: 35146847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
    Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric Symptoms as Predictors of Clinical Course in Neurodegeneration. A Longitudinal Study.
    Santacruz Escudero JM; Beltrán J; Palacios Á; Chimbí CM; Matallana D; Reyes P; Perez-Sola V; Santamaría-García H
    Front Aging Neurosci; 2019; 11():176. PubMed ID: 31396074
    [No Abstract]   [Full Text] [Related]  

  • 39. Malnutrition and neuropsychiatric symptoms in dementia: the Cache County Dementia Progression Study.
    Kauzor K; Drewel M; Gonzalez H; Rattinger GB; Hammond AG; Wengreen H; Lyketsos CG; Tschanz JT
    Int Psychogeriatr; 2023 Nov; 35(11):653-663. PubMed ID: 37246509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease.
    Aarsland D; Cummings JL; Larsen JP
    Int J Geriatr Psychiatry; 2001 Feb; 16(2):184-91. PubMed ID: 11241724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.